Jun 3, 2026 8:12 am EDT VolitionRx Files New Patent Protecting its Nu.Q® NETs Test for Ebola Triage and Treatment Monitoring
May 27, 2026 8:17 am EDT VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets
May 14, 2026 4:10 pm EDT VolitionRx Limited Announces First Quarter 2026 Financial Results and Business Update
May 11, 2026 8:19 am EDT VolitionRx Limited Schedules First Quarter 2026 Earnings Conference Call and Business Update
May 6, 2026 8:17 am EDT VolitionRx Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats
Apr 29, 2026 8:17 am EDT Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis Testing
Mar 31, 2026 4:05 pm EDT VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update
